News

SAN FRANCISCO, July 23, 2020 (ClinicalOMICs) – Jarret Glasscock, CEO of Cofactor Genomics, recently spoke with Patrick Hurban, Senior Director and Global Head, Translational Genomics at [...]

SAN FRANCISCO, July 2020 (PharmaTimes Magazine) – We’ve come a long way from the early days of using medicinal leeches and mercury treatments as therapeutics. As described in the book [...]

SAN FRANCISCO, July 9, 2020 (AWS Web Day) – Keeping the Focus on Patients.  Cofactor was recently featured in the AWS Healthcare and Life Sciences Web Day, with on-demand recordings now [...]

SAN FRANCISCO, May 12, 2020 (HIT CONSULTANT) – World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He [...]

San Francisco, CA – May 6, 2020 (REPORTABLE) – Winners of Cofactor Genomics’ “Functional to FFPE” Grant Program were publicly announced today. Two projects from Dell Medical School at University [...]

SAN FRANCISCO, Calif. – April 16, 2020 – (REPORTABLE) Today, Cofactor Genomics announced the peer-reviewed publication of an analytical validation study demonstrating the performance of its novel [...]

CAMBRIDGE, MA, Mar. 4, 2020 (REPORTABLE) – Video methods for the molecular protocol associated with the Cofactor Genomics ImmunoPrism® Assay are now published in the Journal of Visualized [...]

SAN FRANCISCO, Feb. 28, 2020 (CLINICAL OMICS) – A retrospective study among head and neck cancer patients found that a multivariate RNA biomarker test performed equally as standard PD-L1 [...]

SAN FRANCISCO, Feb. 7, 2020 (DIAGNOSTIC WORLD) – Achieving true precision medicine in oncology continues to challenge the entire healthcare field—from clinicians to drug manufacturers to [...]

SAN FRANCISCO, Jan. 9, 2020 (DRUG TARGET REVIEW) – Modern day oncology therapies have seen significant innovation in the last decade. It is high time we commit to using biomarkers that are [...]